Newsletter Insights — advertising rates and audience data for 45K+ newsletters
Browse all →Track The Vajenda's growth
Get notified when subscribers, engagement, or pricing changes
Platform Portability
Uses Substack subdomain (vajenda.substack.com). Migrating would require subscribers to re-subscribe at a new address.
Custom domains let newsletters switch platforms without losing their audience.
Are you a newsletter creator? Get verified insights →
Imagine a Venn diagram with overlapping circles labeled: Medical Facts, Feminism, and Fire. You've arrived at their intersection.
Data updated Yesterday
Avg Comments
18.5
Avg Likes
194.5
Engagement Rate
0.16%· ~213 likes + comments/post
(comments + likes) / subscribers
Typical for lists with 131K+ subscribers
Quality Score
Engagement vs Health
0.16% engagement rate
Score Breakdown
Engagement Score
| Public |
| Inside the FDA’s Testosterone WorkshopDay 2: Safety Data, Gel Data, and What the FDA is Looking for in SubmissionsSep 23, 2026 | Public |
| The FDA’s Testosterone Hearing: Use in Menopausal WomenPart 1: What We Actually Know About Testosterone for Women and the Current ProductsSep 21, 2026 | Subscriber-only |
| Testosterone to Increase Exercise Capacity in Women with Early Heart Failure: A Randomised Controlled TrialUpdate from the Australasian Menopause Society Annual CongressSep 15, 2026 | Public |
| Bone Health Without the Hype10 lessons from the Australasian Menopause Society meeting: DXA, estrogen doses, and moreSep 13, 2026 | Public |
| The Problem with Compounded TestosteroneWhat is in your product?Sep 4, 2026 | Public |
| Before You Share That New "HRT Prevents Dementia" Study, Read the Fine PrintIt found no benefit for most women, and it’s observationalAug 28, 2026 | Public |
| The Estrogen-Alzheimer’s Hype MachineWhy one observational study can’t turn a hypothesis into a treatmentAug 20, 2026 | Subscriber-only |
| Tell Me About Oestra for Menopause Hormone Therapy?Ask Dr. jenAug 14, 2026 | Public |
| Menopause is Hot: What Google Trends Can Tell UsA New Study Looks at the Menopause Information Ecosystem and EconomyAug 7, 2026 | Public |
11.1K paid
Paid Subscriber Retention
+0.8%
net growth
Track revenue changes over time
Start tracking — freeTrack CPM rates as they change
Start tracking — freeThe Vajenda reports a rounded subscriber count of 131K. The platform doesn't expose finer-grained numbers, so week-to-week changes below the rounding threshold aren't visible in a chart.
Add to your watchlist to get notified the next time the reported count shifts.
vs 135 newsletters in Health
131K places you in the top 10% of newsletters in this category.
Engagement Rate
0.16%
median: 0.00%
Posts per Week
1.5
median: 1.0
Publishing Consistency
79/100
median: 67/100
Subscribers
131K
median: 1K
Here's what we know about this newsletter's activity:
Publishing Pace
Weekly
Consistent
Category Rank
#11 of 582
in Health
Engagement Trend
Consistent
based on recent posts
Nedra Nuggets
153K subs
-0.3%/wk
Sensible Medicine
107K subs
Dr. Jessica Knurick
84K subs
++0.6%/wk
Get email alerts when subscribers drop or spike, when new sponsors appear, when pricing changes, or when publishing cadence shifts. Track unlimited newsletters across your watchlist with the Starter plan.
$29/mo·cancel anytime
See what's includedGet the full whitespace list with each brand's category fit, audience overlap, and recommended pitch order. Plus a comparison of The Vajenda vs the top 15 peer newsletters on sponsor mix, growth, and CPM.
Including Momentous, Maui Nui Venison, GORUCK + 76 more.
$300·2-3 working days·refunded if we can't deliver
Publishing Frequency
Weekly
Last published Oct 1, 2026
Usually publishes Fri, Sun
1.5 posts/week avg
Health Pricing
$6/mo median
Below average(-17%)
Monetization Readiness
Already monetizing
100% of similar-size Health newsletters also have paid tiers
Unlock revenue estimates, CPM benchmarks, and detected sponsors
Start tracking — free131.0K subscribers, 0.16% engagement, and 1 detected sponsor — a strong profile for advertisers.